Cargando…

c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53

SIMPLE SUMMARY: Deregulated expression of the c-MYC oncogene activates the tumor suppressor p53, which has been suggested to represent a failsafe mechanism against the uncontrolled expansion of tumor cells. Here, we analyzed the role of the c-MYC-induced TFAP4/AP4 gene in this context using a geneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaller, Markus, Shi, Wenjing, Hermeking, Heiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954515/ https://www.ncbi.nlm.nih.gov/pubmed/36831504 http://dx.doi.org/10.3390/cancers15041162

Ejemplares similares

Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
por: Siemens, Helge, et al.
Publicado: (2013)

AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p
por: Chou, Jinjiang, et al.
Publicado: (2022)

AP4 is required for mitogen- and c-MYC-induced cell cycle progression
por: Jackstadt, Rene, et al.
Publicado: (2014)

Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity
por: Kaller, Markus, et al.
Publicado: (2017)

p53-Dependent Repression: DREAM or Reality?
por: Peuget, Sylvain, et al.
Publicado: (2021)

Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with p53 mutation and elevated c-MYC expression
por: Du, Yuyun, et al.
Publicado: (2023)

Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer
por: Shi, Xiaolong, et al.
Publicado: (2020)

CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34
por: Huang, Zekai, et al.
Publicado: (2023)

Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells
por: Jaeckel, Stephanie, et al.
Publicado: (2018)

c-MYC and SIRT1 locked in a vicious cycle
por: Menssen, Antje, et al.
Publicado: (2012)

AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation
por: Jackstadt, R, et al.
Publicado: (2013)

The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020)

Interchanging heads: p53 re-composes the DREAM/MMB complex to repress transcription
por: Dobbelstein, Matthias
Publicado: (2013)

Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die
por: Wong, Matthew Man-Kin, et al.
Publicado: (2021)

Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a
por: Liu, Fangteng, et al.
Publicado: (2022)

Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression
por: Rokavec, Matjaz, et al.
Publicado: (2017)

p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3
por: Hünten, Sabine, et al.
Publicado: (2015)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
por: Engeland, Kurt
Publicado: (2018)

DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation
por: Uxa, Sigrid, et al.
Publicado: (2019)

The p53/microRNA connection in gastrointestinal cancer
por: Rokavec, Matjaz, et al.
Publicado: (2014)

Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
por: Hakem, Anne, et al.
Publicado: (2011)

Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer
por: Brennan, Kevin, et al.
Publicado: (2023)

A Combinatorial Code for CPEB-Mediated c-myc Repression
por: Ogami, Koichi, et al.
Publicado: (2023)

SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
por: Loevenich, Leon P., et al.
Publicado: (2022)

AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
por: Jackstadt, Rene, et al.
Publicado: (2013)

RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC
por: Duan, Lei, et al.
Publicado: (2022)

The transcription factor DREAM represses A20 and mediates inflammation
por: Tiruppathi, Chinnaswamy, et al.
Publicado: (2014)

Salicylate induces AMPK and inhibits c-MYC to activate a NRF2/ARE/miR-34a/b/c cascade resulting in suppression of colorectal cancer metastasis
por: Liu, Chunfeng, et al.
Publicado: (2023)

Author Correction: RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC
por: Duan, Lei, et al.
Publicado: (2022)

Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis
por: Rokavec, Matjaz, et al.
Publicado: (2019)

c-Myc-induced transcription factor AP4 is required for CD8(+) T cell-mediated host protection
por: Chou, Chun, et al.
Publicado: (2014)

Transcription factor AP-2α activates RNA polymerase III–directed transcription and tumor cell proliferation by controlling expression of c-MYC and p53
por: Wang, Juan, et al.
Publicado: (2023)

p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes
por: Benson, E K, et al.
Publicado: (2014)

Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
por: Martinez-Zapien, Denise, et al.
Publicado: (2016)

Regulation of the somatotropic axis by MYC-mediated miRNA repression
por: Petrashen, Anna P., et al.
Publicado: (2023)

BRD4-mediated repression of p53 is a target for combination therapy in AML
por: Latif, Anne-Louise, et al.
Publicado: (2021)

A CRISPR/dCasX‐mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c‐MYC or activating TP53
por: Cao, Congcong, et al.
Publicado: (2021)

Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model
por: Borland, Gillian, et al.
Publicado: (2016)

The DREAM complex represses growth in response to DNA damage in Arabidopsis
por: Lang, Lucas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bgjshefi4i5uv8t2dn0khqs7k5